ENTA logo

Enanta Pharmaceuticals (ENTA) Company Overview

Profile

Full Name:

Enanta Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 21, 2013

Indexes:

Not included

Description:

Enanta Pharmaceuticals, Inc. is an American biotechnology company specializing in the development of small molecule drugs for viral infections and liver diseases. The company was founded in 2004 and is headquartered in Hayward, California, USA. Enanta Pharmaceuticals is conducting clinical development in the following areas: RSV (respiratory syncytial virus). RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in children under one year of age in the United States. NASH (non-alcoholic steatohepatitis). HBV (hepatitis B virus) - a potentially life-threatening liver infection.

Key Details

Price

$7.05

Annual Revenue

$67.64 M(-14.61% YoY)

Annual EPS

-$5.48(+14.11% YoY)

Annual ROE

-67.17%

Beta

1.38

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 10, 2025

Recent annual earnings:

Nov 25, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 11, 25 JMP Securities
Market Outperform
Feb 11, 25 HC Wainwright & Co.
Buy
Dec 24, 24 HC Wainwright & Co.
Buy
Nov 26, 24 JMP Securities
Market Outperform
Nov 26, 24 Baird
Outperform
Oct 10, 24 HC Wainwright & Co.
Buy
Oct 9, 24 JMP Securities
Market Outperform
Sep 27, 24 JMP Securities
Market Outperform
Aug 6, 24 JP Morgan
Underweight
Aug 6, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Enanta Pharmaceuticals?
  • Does Enanta Pharmaceuticals pay dividends?
  • What sector is Enanta Pharmaceuticals in?
  • What industry is Enanta Pharmaceuticals in?
  • What country is Enanta Pharmaceuticals based in?
  • When did Enanta Pharmaceuticals go public?
  • Is Enanta Pharmaceuticals in the S&P 500?
  • Is Enanta Pharmaceuticals in the NASDAQ 100?
  • Is Enanta Pharmaceuticals in the Dow Jones?
  • When was Enanta Pharmaceuticals's last earnings report?
  • When does Enanta Pharmaceuticals report earnings?
  • Should I buy Enanta Pharmaceuticals stock now?

What is the ticker symbol for Enanta Pharmaceuticals?

The ticker symbol for Enanta Pharmaceuticals is NASDAQ:ENTA

Does Enanta Pharmaceuticals pay dividends?

No, Enanta Pharmaceuticals does not pay dividends

What sector is Enanta Pharmaceuticals in?

Enanta Pharmaceuticals is in the Healthcare sector

What industry is Enanta Pharmaceuticals in?

Enanta Pharmaceuticals is in the Biotechnology industry

What country is Enanta Pharmaceuticals based in?

Enanta Pharmaceuticals is headquartered in United States

When did Enanta Pharmaceuticals go public?

Enanta Pharmaceuticals's initial public offering (IPO) was on March 21, 2013

Is Enanta Pharmaceuticals in the S&P 500?

No, Enanta Pharmaceuticals is not included in the S&P 500 index

Is Enanta Pharmaceuticals in the NASDAQ 100?

No, Enanta Pharmaceuticals is not included in the NASDAQ 100 index

Is Enanta Pharmaceuticals in the Dow Jones?

No, Enanta Pharmaceuticals is not included in the Dow Jones index

When was Enanta Pharmaceuticals's last earnings report?

Enanta Pharmaceuticals's most recent earnings report was on Feb 10, 2025

When does Enanta Pharmaceuticals report earnings?

The next expected earnings date for Enanta Pharmaceuticals is May 6, 2025

Should I buy Enanta Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions